Here are 15 key notes on orthopedic and spine device companies over the past week.
Johnson & Johnson reported sales of $17.5 billion in the first quarter of 2016, an increase of 0.6 percent compared to the first quarter of 2015.
Medtronic reported fourth quarter worldwide revenue of $7.57 billion, compared to the $7.30 billion reported in the fourth quarter of 2015, a 4 percent increase, or 6 percent on a constant currency basis.
Following the release of Medtronic's fourth quarter and full-year 2016 financial results, CEO Omar Ishrak said the company plans to restructure its restorative therapies group in an earnings conference call.
Paradigm Spine agreed to pay the United States $585,000 to settle False Claims Act allegations, according to the United States Attorney's Office District of Maryland.
Aurora Spine completed a non-brokered private placement of common shares.
Pinnacle Spine Group launched its InFill Anterior Lumbar Interbody Fusion device.
K2M received FDA 510(k) clearances to market its CASCADIA Cervical and CASCADIA AN Lordotic Oblique Interbody Systems featuring Lamellar 3D Titanium Technology.
Spine Wave closed an $11 million financing round.
Implanet nominated Mary E. Shaughnessy to its board of directors.
NuVasive is positioned to see great growth in the international market this year, according to Zacks.
Eden Spine's SPHYNX plating system was granted CE Mark approval.
TransEnterix named Theodore Pappas, MD, as its senior surgical officer.
Vertebral Technologies redesigned the company's brand.
Wright Medical Executive Vice President and COO David Mowry is leaving his position.
The Australian Registry of Therapeutic Goods accepted Tyber Medical's entire interbody family of products.